Balyasny Asset Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-59,755
| Closed | -$1.52M | – | 2353 |
|
|
2024
Q4 | $1.52M | Buy |
+59,755
| New | +$1.52M | ﹤0.01% | 1159 |
|
|
2024
Q1 | – | Sell |
-95,382
| Closed | -$2.68M | – | 2368 |
|
|
2023
Q4 | $2.68M | Buy |
95,382
+27,445
| +40% | +$771K | 0.01% | 959 |
|
|
2023
Q3 | $1.84M | Buy |
+67,937
| New | +$1.84M | ﹤0.01% | 1014 |
|
|
2022
Q4 | – | Sell |
-285,034
| Closed | -$11.5M | – | 2684 |
|
|
2022
Q3 | $11.5M | Buy |
+285,034
| New | +$11.5M | 0.04% | 510 |
|
|
2022
Q2 | – | Sell |
-197,889
| Closed | -$7.71M | – | 2640 |
|
|
2022
Q1 | $7.71M | Buy |
+197,889
| New | +$7.71M | 0.02% | 618 |
|